BPC-157 vs Cortexin
A detailed comparison to help you understand the differences and choose the right peptide for your research goals.
BPC-157
Body Protection Compound-157 is a synthetic peptide derived from a protein found in human gastric juice. It has shown remarkable healing properties in research studies.
Full details →Cortexin
Cortexin is a polypeptide complex derived from pig brain cortex, used clinically in Russia and Eastern Europe for neurological conditions including stroke recovery, traumatic brain injury, and cognitive decline.
Full details →Side-by-Side Comparison
| Aspect | BPC-157 | Cortexin |
|---|---|---|
| Dose Range | 250 mcg–500 mcg | 10 mg–20 mg |
| Frequency | 2x daily | 1x daily |
| Cycle Length | 4–6 weeks | 1–2 weeks |
| Route | subcutaneous | intramuscular |
| Mechanism | BPC-157 works through multiple pathways including upregulation of growth factor expression, nitric oxide system modulation, and promotion of angiogenesis. It enhances tendon-to-bone healing and supports the formation of new blood vessels. | Contains a mixture of neuropeptides and amino acids that support neuronal metabolism, provide neuroprotection, and enhance synaptic transmission. Specific mechanisms not fully characterized. |
| Typical Dosage | Typical research dosages range from 250-500mcg administered 1-2 times daily. Both subcutaneous and oral administration have been studied. | Clinical protocols: 10mg intramuscularly once daily for 10-20 days. May be repeated after 3-6 month interval. |
| Administration | Can be administered subcutaneously near the injury site or systemically. Stable in gastric juice, making oral administration viable. | Intramuscular injection. Comes as lyophilized powder requiring reconstitution. Treatment given in courses rather than continuously. |
| Side Effects | Generally well-tolerated in research. Some reports of mild nausea or dizziness at higher doses. | Generally well-tolerated. May cause injection site reactions or mild allergic responses in sensitive individuals. |
| Best For |
What They Have in Common
BPC-157, Cortexin are both commonly used for:
Key Differences
Unique to BPC-157:
Unique to Cortexin:
Which Has Stronger Evidence?
- Recovery & Healing: BPC-157 has stronger research support.
| Goal | BPC-157 | Cortexin |
|---|---|---|
| Recovery & Healing | high | medium |
Key Studies
BPC-157
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 2025
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.
Current reviews in musculoskeletal medicine, 2025
- Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study.
Alternative therapies in health and medicine, 2024
Cortexin
- [Cortexin in the comprehensive therapy of alcoholic encephalopathy].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2026
- Cortexin modulates OPG/RANK/RANKL and TRPC1 expression in cerebral ischemia-reperfusion injury.
Neurological research, 2026
- Neurotropic Effects of Cortexin on Models of Mental and Physical Developmental Delay.
Biomedicines, 2025
Ready to Learn More?
Looking for trusted sources?